Technical Analysis for ALLO - Allogene Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| 20 DMA Resistance | Bearish | 0.68% | |
| 200 DMA Resistance | Bearish | 0.68% | |
| New Uptrend | Bullish | 0.68% | |
| Pocket Pivot | Bullish Swing Setup | 0.68% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 17 hours ago |
| 20 DMA Resistance | about 17 hours ago |
| Possible Inside Day | about 19 hours ago |
| Possible Pocket Pivot | about 21 hours ago |
| 2x Volume Pace | about 23 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/05/2024
Allogene Therapeutics is a clinical stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer. Led by a world-class management team with significant experience in cell therapy, we are developing a pipeline of “off-the-shelf” CAR T cell therapy candidates with the goal of delivering readily available cell therapy faster, more reliably and at greater scale to more patients.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Life Sciences Stem Cell Cell Therapy Cell Biology Therapies For Cancer Adoptive Cell Transfer
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Life Sciences Stem Cell Cell Therapy Cell Biology Therapies For Cancer Adoptive Cell Transfer
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 6.405 |
| 52 Week Low | 2.23 |
| Average Volume | 2,257,635 |
| 200-Day Moving Average | 3.58 |
| 50-Day Moving Average | 3.82 |
| 20-Day Moving Average | 3.01 |
| 10-Day Moving Average | 2.92 |
| Average True Range | 0.27 |
| RSI (14) | 40.48 |
| ADX | 26.4 |
| +DI | 28.71 |
| -DI | 19.44 |
| Chandelier Exit (Long, 3 ATRs) | 2.84 |
| Chandelier Exit (Short, 3 ATRs) | 3.51 |
| Upper Bollinger Bands | 3.46 |
| Lower Bollinger Band | 2.56 |
| Percent B (%b) | 0.47 |
| BandWidth | 29.91 |
| MACD Line | -0.25 |
| MACD Signal Line | -0.30 |
| MACD Histogram | 0.0497 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.42 | ||||
| Resistance 3 (R3) | 3.46 | 3.35 | 3.34 | ||
| Resistance 2 (R2) | 3.35 | 3.24 | 3.33 | 3.32 | |
| Resistance 1 (R1) | 3.17 | 3.17 | 3.12 | 3.13 | 3.29 |
| Pivot Point | 3.06 | 3.06 | 3.04 | 3.04 | 3.06 |
| Support 1 (S1) | 2.88 | 2.95 | 2.83 | 2.84 | 2.67 |
| Support 2 (S2) | 2.77 | 2.88 | 2.75 | 2.64 | |
| Support 3 (S3) | 2.59 | 2.77 | 2.62 | ||
| Support 4 (S4) | 2.55 |
